Inflammatory invasion on human vaginal mucosa correlated with combined drug treatment and recurrence in recurrent vulvovaginal candidiasis
Journal of Obstetrics and Gynaecology Research · 2023-05 · 49 (5) · 1443-1451
DOI: 10.1111/jog.15577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 11.02.2023. Verfasst von Xinyi He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, the First Affiliated Hospital of Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Aim
Recurrent vulvovaginal candidiasis (RVVC) is a chronic, difficult to treat vaginal infection, caused by Candida species, which affects women of all ages and ethnic and social background. Most RVVC studies use animal models, and there is still a lack of observation on human tissue samples and effective therapy to reduce recurrence. Materials and Methods We observed CD163 + macrophages and NLRP3 expression by immunohistochemistry, also investigated bacteria and fungi co‐invasion by fluorescence in situ hybridization from 144 human vaginal biopsy tissues (48 RVVC, 48 VVC, 48 healthy volunteers), and we also explored the effect of combining metronidazole in the treatment of RVVC.
Results
A large number of neutrophils, lymphocytes and plasma cells infiltrated the mucosa, basement membrane and submucosa, accompanied by significantly overexpressed NLRP3 inflammasome. While CD163 + macrophages often infiltrated under the basement membrane in patients with RVVC, 29.2% of cases were found Gardnerella and fungi jointly invaded the vaginal mucosas. RVVC vaginal mucosal histopathology revealed mucosal inflammatory responses dominated by neutrophils, which may involve activation of NLRP3 and immune tolerance of M2 macrophages (CD163 + ). Fluconazole combined with metronidazole can achieve higher efficiency (95.8% vs. 70.8%) and reduce the recurrence rate more (8.3% vs. 37.5%) at 6‐month follow‐up.
Conclusion
Inflammatory invasion on human vaginal mucosa correlated with combined drug treatment and recurrence in RVVC. The combined medication will need to further evaluate in future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, the First Affiliated Hospital of Jinan University, Guangzhou, China.
- Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Obstetrics and Gynecology, Huizhou Second Maternal and Child Health Hospital of Guangdong, Huizhou, China.
- The Molecular Genetic Laboratory for Polymicrobial Infections und Biofilms, Universitatsmedizin Berlin, Berlin, Germany.
ORCID-Profile: Xuefeng Jiang
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
He, X., Tang, Q., Zhan, F., Mao, Y., Ye, F., Weng, Z., Jiang, X., & Swidsinski, A. (2023). Inflammatory invasion on human vaginal mucosa correlated with combined drug treatment and recurrence in recurrent vulvovaginal candidiasis. Journal of Obstetrics and Gynaecology Research, 49(5), 1443-1451. https://doi.org/10.1111/jog.15577
Vancouver
He X, Tang Q, Zhan F, Mao Y, Ye F, Weng Z, et al. Inflammatory invasion on human vaginal mucosa correlated with combined drug treatment and recurrence in recurrent vulvovaginal candidiasis. Journal of Obstetrics and Gynaecology Research. 2023;49(5):1443-1451. doi:10.1111/jog.15577
BibTeX
@article{He2023,
author = {He, Xinyi and Tang, Qionglan and Zhan, Fengshu and Mao, Yiwen and Ye, Fei and Weng, Zeping and Jiang, Xuefeng and Swidsinski, Alexander},
title = {Inflammatory invasion on human vaginal mucosa correlated with combined drug treatment and recurrence in recurrent vulvovaginal candidiasis},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2023},
volume = {49},
number = {5},
pages = {1443--1451},
doi = {10.1111/jog.15577}
}
EUVIMED